Moleculin Biotech Inc. (NASDAQ: MBRX) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT MOLECULIN BIOTECH INC.

Moleculin Biotech Inc. (NASDAQ: MBRX)
Listen to this Section


$1.00
-0.2300 ( -21.26% ) 237.6K

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Market Data


Open $1.00
Previous Close $1.23
Volume 237.6K
Market Cap $4.22M
Day Range $1.00 - $1.55
52 Week Range $1.00 - $10.35
Shares Outstanding 3.38M
Change % -21.26%
Net Change ▼ -0.2300
Insider Ownership -0.03%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2016
Country United States

Insider Ownership Transactions

Total Amount Purchased: 205,775.00

Date Type Amount Purchased Purchaser
2024-07-05 Sale -982.00 KLEMP WALTER V
2024-06-25 Sale -4329.00 Foster Jonathan P.
2024-06-25 Sale -8990.00 KLEMP WALTER V
2024-06-25 Sale -1766.00 PICKER DONALD H
2024-06-21 Sale -2712.00 Foster Jonathan P.
2024-06-21 Sale -1078.00 PICKER DONALD H
2024-06-21 Sale -3750.00 KLEMP WALTER V
2024-06-18 Sale -834.00 Foster Jonathan P.
2024-06-18 Sale -1667.00 KLEMP WALTER V
2023-12-27 Buy 28986.00 Foster Jonathan P.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Nov 06, 2024
4 Insider transactions 1 Nov 06, 2024
4 Insider transactions 1 Nov 06, 2024
4 Insider transactions 1 Nov 06, 2024
8-k 8K-related 17 Nov 05, 2024
s-8 Registration statements 6 Oct 25, 2024
8-k 8K-related 16 Oct 25, 2024
8-k 8K-related 49 Oct 17, 2024
8-k 8K-related 16 Oct 07, 2024
8-k 8K-related 46 Oct 02, 2024

Latest News


× Before browsing our site, please accept our cookies policy